These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 18432838)
1. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC). Nelson DL; Kurman CC; Serbousek DE Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.27. PubMed ID: 18432838 [TBL] [Abstract][Full Text] [Related]
2. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies. Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226 [TBL] [Abstract][Full Text] [Related]
3. Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays. Chung S; Nguyen V; Lin YL; Kamen L; Song A J Immunol Methods; 2017 Aug; 447():37-46. PubMed ID: 28434980 [TBL] [Abstract][Full Text] [Related]
4. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays. Mata MM; Mahmood F; Sowell RT; Baum LL J Immunol Methods; 2014 Apr; 406():1-9. PubMed ID: 24561308 [TBL] [Abstract][Full Text] [Related]
5. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells. Chung S; Lin YL; Reed C; Ng C; Cheng ZJ; Malavasi F; Yang J; Quarmby V; Song A J Immunol Methods; 2014 May; 407():63-75. PubMed ID: 24704820 [TBL] [Abstract][Full Text] [Related]
6. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells. Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954 [TBL] [Abstract][Full Text] [Related]
7. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals. Fauci AS; Balow JE; Pratt KR J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955 [TBL] [Abstract][Full Text] [Related]
8. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells. Brier AM; Chess L; Schlossman SF J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988 [TBL] [Abstract][Full Text] [Related]
10. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716 [TBL] [Abstract][Full Text] [Related]
11. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro. Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918 [TBL] [Abstract][Full Text] [Related]
12. Methods for measuring antibody-dependent cell-mediated cytotoxicity in vitro. Miller AS; Tejada ML; Gazzano-Santoro H Methods Mol Biol; 2014; 1134():59-65. PubMed ID: 24497354 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging. Jondal M Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801 [TBL] [Abstract][Full Text] [Related]
14. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells. Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412 [TBL] [Abstract][Full Text] [Related]
16. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell. Melewicz FM; Shore SL; Ades EW; Phillips DJ J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428 [TBL] [Abstract][Full Text] [Related]
17. A method for determination of antibody-dependent cellular cytotoxicity (ADCC) of human peripheral mononuclear cells. Wisecarver J; Bechtold T; Collins M; Davis J; Lipscomb H; Sonnabend J; Purtilo DT J Immunol Methods; 1985 May; 79(2):277-82. PubMed ID: 3998480 [TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. Peters CJ; Theofilopoulos AN J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469 [TBL] [Abstract][Full Text] [Related]
19. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ MAbs; 2015; 7(3):494-504. PubMed ID: 25933349 [TBL] [Abstract][Full Text] [Related]
20. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC). Christiaansen JE; Burnside SS; Sears DW J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]